Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

24.02
BATS BZX Real-Time Price
As of 1:22pm ET
 +0.73 / +3.13%
Today’s Change
19.59
Today|||52-Week Range
65.34
-61.21%
Year-to-Date
These 3 Biotechs Are Down More Than 36% This Year, and They're Bargains
Jun 29 / MotleyFool.com - Paid Partner Content
These 5 Biotech Stocks Are Ridiculously Cheap
Jun 21 / MotleyFool.com - Paid Partner Content
Better Buy: NantKwest, Inc. vs. Ionis Pharmaceuticals
Jun 28 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close23.29
Today’s open23.38
Day’s range23.27 - 24.48
Volume62,288
Average volume (3 months)2,377,599
Market cap$2.8B
Dividend yield--
Data as of 1:22pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)-124.24%
Earnings growth (this year)--
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+32.47%
P/E ratioNM
Price/Sales26.13
Price/Book13.96

Competitors

 Today’s
change
Today’s
% change
PRAHPRA Health Sciences ...-0.77-1.85%
PRXLPAREXEL Internationa...+0.37+0.59%
INCRINC Research Holding...-0.17-0.45%
NKTRNektar Therapeutics+0.01+0.07%
Data as of 1:23pm ET, 07/01/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$283.7M
Annual profit (last year)-$88.3M
Net profit margin-31.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts

Partner Offers

Search for Jobs